Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Russ Smith


Clinical Trial Administrator

Brief Bio

Started working on the national PRINCIPLE trial of potentially ameliorative drugs for early Covid 19 symptoms in October 2020, from recruitment to current final trial closure processes; main tasks/duties now centre on assisting the inception and administration of the three international STEP trials (ASSIST, ENHANCE, PROMOTE) into the efficacy of cannabidiol (CBD) on symptoms of early stage psychosis (Stratification and Treatment of Early Psychosis).